Blog
RSS FeedPosted by Michael Wonder on 07 Nov 2019
Paying £500 million more a week for drugs post-Brexit is based on a fairly extreme scenario
7 November 2019 - The UK could pay £500 million more per week for drugs following a post-Brexit trade deal with ...
Posted by Michael Wonder on 07 Nov 2019
Brexit: what it could mean for drug prices
5 November 2019 - Trading away the UK’s rights to drive down drug prices could cost the NHS half a ...
Posted by Michael Wonder on 06 Nov 2019
Corbyn accuses Tories of planning deal to hike drug prices with Trump as election looms
5 November 2019 - Drug prices have become an issue in the UK’s general election, after Labour leader Jeremy Corbyn ...
Posted by Michael Wonder on 05 Nov 2019
NICE International returns to deal with growing overseas enquiries
5 November 2019 - Division will offer an advisory service to international organisations, ministries and government agencies. ...
Posted by Michael Wonder on 31 Oct 2019
NICE terminates another two assessments for cancer medicines
30 October 2019 - One medicine is from Janssen; the other is from Eli Lilly. ...
Posted by Michael Wonder on 29 Oct 2019
NHS bill for US drugs 'could soar under post-Brexit trade deal'
28 October 2019 - Dispatches investigation finds 'drug pricing' has been discussed in six initial meetings between trade officials from the ...
Posted by Michael Wonder on 29 Oct 2019
UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks
29 October 2019 - Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’. ...
Posted by Michael Wonder on 28 Oct 2019
NICE to support new valuation study for England for EQ-5D-5L questionnaire
24 October 2019 - Study will measure public’s preference for different health states. ...
Posted by Michael Wonder on 24 Oct 2019
NHSE signs ‘definitive’ agreement for Vertex CF drugs
24 October 2019 - NHS England has announced a definitive agreement with Vertex Pharmaceuticals to make all three of their ...
Posted by Michael Wonder on 23 Oct 2019
Cystic fibrosis: NHS patients in England to get life-transforming drugs 'within weeks'
23 October 2019 - Orkambi and Symkevi have been shown to radically the improve lung function of sufferers - but were ...
Posted by Michael Wonder on 22 Oct 2019
Evolution or revolution: the latest review of NICE methods
22 October 2019 - The UK’s NICE doesn’t stand still, having seen many changes during its 20 year existence. ...
Posted by Michael Wonder on 22 Oct 2019
Roche app allows access to latest cancer guidelines
21 October 2019 - Roche has launched an app allowing access to the latest guidelines covering the most common forms ...
Posted by Michael Wonder on 18 Oct 2019
NICE ‘ok’ for Bayer’s Xarelto
18 October 2019 - NICE has published the final appraisal determination for Xarelto (rivaroxaban). ...
Posted by Michael Wonder on 11 Oct 2019
Another treatment option for ovarian cancer approved for the Cancer Drugs Fund
11 October 2019 - An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE ...
Posted by Michael Wonder on 10 Oct 2019
Biosimilars in the UK: where are we now and where does the NHS want to go?
9 October 2019 - The UK health service has well over a decade’s experience of dealing with biosimilars, but the ...